Chris brings with him 25+ years practical and academic experience within the pharmaceutical industry, across both Marketing and R&D having been Director of Global Pricing and Market Access (Oncology) at Astra Zeneca, Director Health Economics, Pricing, Reimbursement and Access at Allergan, Commercial Planning Manager at Fisons, and Portfolio Planning Manager at Novartis in Switzerland.

For the past 10 years he worked in Consultancy (Bridgehead International, GfK, and Ipsos) and in 2023 founded TealeHealth Ltd, a consultancy providing expert Advisory, Access, and Analytic support on Advanced Personalised Therapies.Chris brings significant experience of identifying and overcoming hurdles along the whole value chain - clinical development, manufacturing, distribution, regulatory assessment, health technology assessment, market access, pricing, marketing, and product uptake.

He specialises in helping companies understand the value and sustainability of their differentiation relative to the competition and the evidence requirements to underpin this.Chris has a mathematics and operational research background having studied at Newcastle and Loughborough universities, and at INSEAD Business School in France. He is an occasional lecturer on health economics and pharmaceutical pricing and reimbursement at Kings College London and University of California (San Diego), a member of ISPOR (International Society for Pharmacoeconomics and Outcomes Research) and PMSA (Pharmaceutical Management Science Association).